122 related articles for article (PubMed ID: 37990538)
1. Deaths averted: An unbiased alternative to rate ratios for measuring the performance of cancer screening programs.
Deck W; Hanley JA
J Med Screen; 2023 Nov; ():9691413231215963. PubMed ID: 37990538
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
4. Interventions targeted at women to encourage the uptake of cervical screening.
Staley H; Shiraz A; Shreeve N; Bryant A; Martin-Hirsch PP; Gajjar K
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD002834. PubMed ID: 34694000
[TBL] [Abstract][Full Text] [Related]
5. Impact of Joint Lung Cancer Screening and Cessation Interventions Under the New Recommendations of the U.S. Preventive Services Task Force.
Meza R; Cao P; Jeon J; Taylor KL; Mandelblatt JS; Feuer EJ; Lowy DR
J Thorac Oncol; 2022 Jan; 17(1):160-166. PubMed ID: 34648947
[TBL] [Abstract][Full Text] [Related]
6. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
National Lung Screening Trial Research Team
J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. Disaggregating the mortality reductions due to cancer screening: model-based estimates from population-based data.
Hanley JA; Njor SH
Eur J Epidemiol; 2018 May; 33(5):465-472. PubMed ID: 29209939
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer deaths averted over 3 decades.
Hendrick RE; Baker JA; Helvie MA
Cancer; 2019 May; 125(9):1482-1488. PubMed ID: 30740647
[TBL] [Abstract][Full Text] [Related]
10. Annual number of lung cancer deaths potentially avertable by screening in the United States.
Ma J; Ward EM; Smith R; Jemal A
Cancer; 2013 Apr; 119(7):1381-5. PubMed ID: 23440730
[TBL] [Abstract][Full Text] [Related]
11. Cost of a population-based programme of chest x-ray screening for lung cancer.
Dominioni L; Rotolo N; Poli A; Castiglioni M; Mangini M; Spagnoletti M; Paolucci M; Paddeu A; Mantovani W; Zanini A; Imperatori A
Monaldi Arch Chest Dis; 2013 Jun; 79(2):67-72. PubMed ID: 24354094
[TBL] [Abstract][Full Text] [Related]
12. Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling.
McMahon PM; Meza R; Plevritis SK; Black WC; Tammemagi CM; Erdogan A; ten Haaf K; Hazelton W; Holford TR; Jeon J; Clarke L; Kong CY; Choi SE; Munshi VN; Han SS; van Rosmalen J; Pinsky PF; Moolgavkar S; de Koning HJ; Feuer EJ
PLoS One; 2014; 9(6):e99978. PubMed ID: 24979231
[TBL] [Abstract][Full Text] [Related]
13. Responding to the challenges of breast cancer in egypt and other arab countries.
El Saghir NS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
